High‐Sensitivity C‐Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction‐Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography
Journal of the American Heart Association · 06.02.2024 · 13 (3)
DOI: 10.1161/jaha.123.032997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 06.02.2024. Verfasst von Xiao-Dong Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Heart Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou China. Hauptthemen laut MEDLINE: Heart Failure, Non-alcoholic Fatty Liver Disease, Coronary Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Systemic chronic inflammation plays a role in the pathophysiology of both heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction‐associated fatty liver disease. This study aimed to investigate whether serum hs‐CRP (high‐sensitivity C‐reactive protein) levels were associated with the future risk of heart failure (HF) hospitalization in patients with metabolic dysfunction‐associated fatty liver disease and a normal left ventricular ejection fraction. Methods and Results The study enrolled consecutive individuals with metabolic dysfunction‐associated fatty liver disease and normal left ventricular ejection fraction who underwent coronary angiography for suspected coronary heart disease. The study population was subdivided into non‐HF, pre‐HFpEF, and HFpEF groups at baseline. The study outcome was time to the first hospitalization for HF. In 10 019 middle‐aged individuals (mean age, 63.3±10.6 years; 38.5% women), the prevalence rates of HFpEF and pre‐HFpEF were 34.2% and 34.5%, with a median serum hs‐CRP level of 4.5 mg/L (interquartile range, 1.9–10 mg/L) and 5.0 mg/L (interquartile range, 2.1–10.1 mg/L), respectively. Serum hs‐CRP levels were significantly higher in the pre‐HFpEF and HFpEF groups than in the non‐HF group. HF hospitalizations occurred in 1942 (19.4%) patients over a median of 3.2 years, with rates of 3.7% in non‐HF, 20.8% in pre‐HFpEF, and 32.1% in HFpEF, respectively. Cox regression analyses showed that patients in the highest hs‐CRP quartile had a ≈4.5‐fold increased risk of being hospitalized for HF compared with those in the lowest hs‐CRP quartile (adjusted‐hazard ratio, 4.42 [95% CI, 3.72–5.25]).
Conclusions
There was a high prevalence of baseline pre‐HFpEF and HFpEF in patients with metabolic dysfunction‐associated fatty liver disease and suspected coronary heart disease. There was an increased risk of HF hospitalization in those with elevated hs‐CRP levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The Heart Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou China.
- Medical Care Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou China.
- Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province Wenzhou Medical University Wenzhou China.
- Department of Medicine University of Verona Italy.
- Metabolic Diseases Research Unit IRCCS Sacro Cuore-Don Calabria Hospital Negrar di Valpolicella (VR) Italy.
- Southampton National Institute for Health and Care Research Biomedical Research Centre University Hospital Southampton, and University of Southampton, Southampton General Hospital Southampton United Kingdom.
ORCID-Profile: Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael D Shapiro, Ki-Chul Sung, Gregory Y H Lip, Ming-Hua Zheng
Zitieren
APA
Zhou, X. D., Chen, Q. F., Targher, G., Byrne, C. D., Shapiro, M. D., Tian, N., Xiao, T., Sung, K. C., Lip, G. Y. H., & Zheng, M. H. (2024). High‐Sensitivity C‐Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction‐Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association, 13(3). https://doi.org/10.1161/jaha.123.032997
Vancouver
Zhou XD, Chen QF, Targher G, Byrne CD, Shapiro MD, Tian N, et al. High‐Sensitivity C‐Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction‐Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association. 2024;13(3). doi:10.1161/jaha.123.032997
BibTeX
@article{Zhou2024,
author = {Zhou, Xiao-Dong and Chen, Qin-Fen and Targher, Giovanni and Byrne, Christopher D and Shapiro, Michael D and Tian, Na and Xiao, Tie and Sung, Ki-Chul and Lip, Gregory Y H and Zheng, Ming-Hua},
title = {High‐Sensitivity C‐Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction‐Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {3},
doi = {10.1161/jaha.123.032997}
}
EUVIMED